Literature DB >> 61174

Rapid quantitation of interferon with chronically oncornavirus-producing cells.

M Aboud, O Weiss, S Salzberg.   

Abstract

The capacity of interferon to inhibit virus production in cells chronically infected with oncornavirus enabled us to develop a simple system for interferon quantitation that was independent of exogenous viral infection. The release of the virus to the culture medium was determined by its reverse transcriptase activity. The inhibitory effect of interferon in this system was linearly proportional to the log of its dilution over a range between 5 and 80% inhibiton. The sensitivity of the system was comparable to that of the vexicular stomatitis virus plaque reduction assay, whereas its reproducibility was found to be even better. This method is very rapid and can be completed within less than 24 h.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61174      PMCID: PMC420811          DOI: 10.1128/iai.13.6.1626-1632.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  COMPARATIVE STUDIES ON THE PRODUCTION AND ASSAY OF INTERFERON.

Authors:  G E GIFFORD; M V MUSSETT; E HELLER
Journal:  J Gen Microbiol       Date:  1964-03

2.  QUANTITATIVE HAEMADSORPTION, A NEW ASSAY TECHNIQUE. I. ASSAY OF INTERFERON.

Authors:  N B FINTER
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

3.  A SENSITIVE METHOD FOR INTERFERON ASSAY.

Authors:  S HERMODSSON; L PHILIPSON
Journal:  Proc Soc Exp Biol Med       Date:  1963-12

4.  Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon.

Authors:  J LINDENMANN; G E GIFFORD
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Heterogeneity of purified mouse interferons.

Authors:  E Knight
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

7.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

8.  Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.

Authors:  R M Friedman; J M Ramseur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

9.  RNase inhibition of reverse transcriptase activity in human milk.

Authors:  J J McCormick; L J Larson; M A Rich
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

10.  C-type virus released from cultured human rhabdomyosarcoma cells.

Authors:  R M McAllister; M Nicolson; M B Gardner; R W Rongey; S Rasheed; P S Sarma; R J Huebner; M Hatanaka; S Oroszlan; R V Gilden; A Kabigting; L Vernon
Journal:  Nat New Biol       Date:  1972-01-05
View more
  16 in total

1.  Viral genome RNA serves as messenger early in the infectious cycle of murine leukemia virus.

Authors:  R Shurtz; S Dolev; M Aboud; S Salzberg
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Enhancement of cellular protein synthesis sensitivity to diphtheria toxin by interferon.

Authors:  M Aboud; T Michalski-Stern; Y Nitzan; S Salzberg
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

3.  Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus.

Authors:  S Salzberg; M Bakhanashvili; S Bari; I Berman; M Aboud
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Cytoplasmic viral DNA synthesis in exogenous infection of murine leukemia virus: effect of interferon and cycloheximide.

Authors:  M Aboud; D Moldovan-Levin; S Salzberg
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

5.  Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells.

Authors:  C W Czarniecki; T Sreevalsan; R M Friedman; A Panet
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

6.  Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.

Authors:  S Salzberg; D H Wreschner; F Oberman; A Panet; M Bakhanashvili
Journal:  Mol Cell Biol       Date:  1983-10       Impact factor: 4.272

7.  Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.

Authors:  M Aboud; Y Hassan
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

8.  Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon.

Authors:  M Aboud; R Kimchi; M Bakhanashvili; S Salzberg
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

9.  Generation of lipopolysaccharide-induced interferon in spleen cell cultures. I. Genetic analysis and cellular requirements.

Authors:  O Ascher; R N Apte; D H Pluznik
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Effect of interferon on the penetration of murine leukemia virus and the binding of its genome RNA to polyribosomes at the early stage of infection.

Authors:  S Salzberg; R Shurtz; J Feder; M Aboud
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.